Adding the targeted drug cetuximab to a three-drug chemotherapy regimen for first-line treatment of metastatic colorectal cancer does not improve response rate, progression-free survival or overall survival, researchers reported at the 35th Congress of the European Society for Medical Oncology (ESMO) in Milan, Italy.
Phase-III data presented at 35th ESMO Congress
A subset of lung cancer patients seem to live longer and experience delays in disease progression when a new drug that targets a cancer-associated molecule called MET is added to treatment with erlotinib, the results of a double-blind Phase-II trial show.
New data reported at the 35th ESMO Congress
A new type of breast cancer treatment has shown encouraging activity as a first-line therapy in HER2-positive metastatic disease, researchers reported at the 35th Congress of the European Society for Medical Oncology (ESMO) in Milan, Italy.
EMBL-EBI researchers present global map of human gene expression
Heidelberg, 1 April 2010 – Name a human gene, and you’ll find a movie online showing you what happens to cells when it is switched off.
A new discovery about the way the brain understands the visual input from the eyes.
Discovery by CIMeC researchers published in the journal Current Biology.
The German Minister for Education and Research officially opens the EMBL Advanced Training Centre – Funding comes from the German Ministry for Education and Research, the Klaus Tschira Foundation, the federal state of Baden-Württemberg and EMBL’s member states
EMBL scientists present genetic catalogue of our gut flora